Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.

about

Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.

Item

http://www.wikidata.org/entity/Q50057440

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Optimal donor for severe aplas ...... large-sample study from China.

@en

Optimal donor for severe aplas ...... large-sample study from China.

@nl

type

Item

label

Optimal donor for severe aplas ...... large-sample study from China.

@en

Optimal donor for severe aplas ...... large-sample study from China.

@nl

prefLabel

Optimal donor for severe aplas ...... large-sample study from China.

@en

Optimal donor for severe aplas ...... large-sample study from China.

@nl

P1476

Optimal donor for severe aplas ...... large-sample study from China.

@en

P2093

Jiang Fan Zhong

http://www.w3.org/2001/XMLSchema#string

Jishi Wang

http://www.w3.org/2001/XMLSchema#string

Lei Gao

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Lihui Peng

http://www.w3.org/2001/XMLSchema#string

Qiang Liu

http://www.w3.org/2001/XMLSchema#string

Sanbin Wang

http://www.w3.org/2001/XMLSchema#string

Xi Zhang

http://www.w3.org/2001/XMLSchema#string

Xuemei Zhang

http://www.w3.org/2001/XMLSchema#string

Yanqi Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Management of the refractory aplastic anemia patient: what are the options?

Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.

observational studies: propensity score analysis of non-randomized data.

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor

Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

P304

2479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-20853-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29410500

http://www.w3.org/2001/XMLSchema#string

P932

5802708

http://www.w3.org/2001/XMLSchema#string